Today marks a significant milestone in our journey. As of December 1, 2023, Crimcheck has officially rebranded to DISA Global Solutions. This change symbolizes more than a new name; it represents our continued commitment to excellence and innovation in employee screening services. Since our acquisition by DISA in 2022, we have worked diligently to integrate the best of both organizations. We are excited to step into this new chapter as DISA Global Solutions, and we are committed to bringing you the same trusted service you are accustomed to receiving. We understand that change, even when posi ..read more

Beginning January 1, 2024, access to the DOT’s drug and alcohol MIS (DAMIS) will transition to Login.gov. As part of the transition, Login.gov requires multifactor authentication, which removes the ability for TPAs to submit this content for customers. Submissions must now be completed by the DOT-regulated employers themselves.  This update is specifically for DOT-regulated employers required to submit their annual drug and alcohol testing information. Agencies within the DOT, including the FTA, FRA, FMCSA, PHMSA, and FAA, will all be part of this change. We have included a table of sub ..read more

On November 7, 2023, Ohio voters passed Ohio Issue 2, Marijuana Legalization Initiative (Issue 2), legalizing recreational cannabis in the state. Issue 2 is a voter initiative, meaning that the legislature may still choose to adjust or, in rare cases, even repeal the initiative.   What Does Issue 2 Do?   Issue 2 legalizes and regulates recreational cannabis for adults aged 21 and older. Under Issue 2, adults can possess up to 2.5 ounces of cannabis, and up to 15 grams of cannabis concentrates, and can cultivate up to six cannabis plants at home (up to 12 per household ..read more

The world of illicit drugs has seen a shift largely driven by the emergence of fentanyl. Allen Johnson, VP of Marketing, Psychemedics, recently presented a webinar for DISA covering the essential information about fentanyl followed by Q&A with attendees. Here are some of the most common questions Allen sees on the topic. Common Questions about Fentanyl Use and Testing Will a standard 10-panel test detect Fentanyl?  Fentanyl isn’t a substance that is tested on standard 10-panel tests. You can run it as a standalone test, and it would be detected. Alternatively, it can be seamlessl ..read more

Since our acquisition in 2022, DISA has been a remarkable partner behind the scenes for our clients. We are grateful that DISA and Crimcheck both place an absolute priority on the client experience. With their assistance, we enhanced our security beyond industry standards. We will continue to leverage their deep expertise to improve operational efficiency while expanding both our coverage and suite of services. Additionally, we believe our clients are already familiar with the DISA brand as a leading provider of employee screening and their continued pursuit of excellence. A few months ago ..read more

DISA Global Solutions is excited to share a remarkable achievement with our clients and partners: the successful completion of the 3-year interim surveillance audit under the Professional Background Screening Association (PBSA). This milestone is a testament to our unwavering commitment to excellence, compliance, and the highest professional standards in the background screening industry.  Receiving and maintaining accreditation requires a dedication to upholding stringent standards and a meticulous evaluation of internal operating procedures. Under the Background Screening Organization ..read more

The world of illicit drugs has seen a shift largely driven by the emergence of fentanyl. This blog will guide you through the myths and truths surrounding fentanyl and testing methods that will appropriately find fentanyl. Allen Johnson, VP of Marketing, Psychemedics, recently presented a webinar for DISA covering the essential and need-to-know information about fentanyl.  Here’s a summary of everything he discussed.  Myths and Truths About Fentanyl   MYTH 1: Fentanyl is a new drug that has been perpetuated by the media mostly due to consistently getting news about overdo ..read more

As of October 1, 2023, significant changes to California’s Fair Chance Act (FCA) compliance have taken effect, impacting both employers and job applicants. This act is designed to provide individuals with criminal histories a fair chance of employment. Morgan Reynolds, VP of Risk and Legal Council, DISA Global Solutions, presented a webinar to discuss the new compliance update followed by an insightful Q&A from the attendees. Here’s what you need to know from the Q&A. Q&A from Webinar Do I have to give the applicant my individualized assessment?   You ..read more

In the last few years, the world has grappled with an unprecedented challenge – the rapid proliferation of the deadly drug, fentanyl. This synthetic opioid, which was once only known in the medical community as a potent painkiller, has now wreaked havoc on communities, families, and workplaces. Governor Abbott’s recent proclamation, declaring October 2023 as Fentanyl Poisoning Awareness Month in Texas, underscores the magnitude and urgency of this crisis.  Understanding Fentanyl and Its Risks Originally designed for treating patients with severe pain, fentanyl is no ordinary drug. Its p ..read more

Understanding California’s Fair Chance Act (FCA) Compliance in 2023 As of October 1, 2023, significant changes to California’s Fair Chance Act (FCA) compliance have taken effect, impacting both employers and job applicants. This act is designed to provide individuals with criminal histories a fair chance of employment. Morgan Reynolds, VP of Risk and Legal Council, DISA Global Solutions, presented a webinar to discuss the new compliance update. Here’s a closer look at what he discussed and what you need to know about California FCA compliance changes. Existing California FCA Compliance (Befor ..read more